BTE vs NESR

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score data, which raises transparency and solvency concerns. Despite trading below its Graham Number of $4.22 at $3.32, the stock shows deteriorating fundamentals, including sharply negative earnings and revenue growth (YoY: -82.6% and -12.3%, respectively), weak profitability trends, and a deteriorating technical trend (10/100). While the dividend appears sustainable with a 32% payout ratio, the current ratio of 0.58 signals near-term liquidity pressure. The company's inconsistent earnings performance, with frequent large misses and volatility in surprises, undermines confidence in its operational predictability.

NESR exhibits strong operational health with a Piotroski F-Score of 7/9, though it lacks an Altman Z-Score for bankruptcy risk assessment. While the company shows impressive price momentum and a low Forward P/E of 9.72, the current price of $23.25 trades at a massive premium compared to its Graham Number ($10.60) and Intrinsic Value ($3.64). The disconnect between deterministic value and market price suggests the stock is priced for aggressive future growth rather than current fundamentals. Overall, the strong balance sheet and revenue growth are offset by extreme valuation stretching.